Related references
Note: Only part of the references are listed.Multiple Myeloma
Jacob Laubach et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma
Ioanna Papandreou et al.
BLOOD (2011)
Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease
Kori Volkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
S. K. Martin et al.
LEUKEMIA (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
PI3K/p110δ is a novel therapeutic target in multiple myeloma
Hiroshi Ikeda et al.
BLOOD (2010)
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
Tina Bagratuni et al.
BLOOD (2010)
Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound-Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
Diana Cirstea et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells
S. Colla et al.
LEUKEMIA (2010)
Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications
Teru Hideshima et al.
BLOOD (2009)
The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
Hiroshi Ikeda et al.
CLINICAL CANCER RESEARCH (2009)
XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells
Chih-Chi Andrew Hu et al.
EMBO JOURNAL (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein C
Mei Dong et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
Inki Kim et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Regulation of hepatic lipogenesis by the transcription factor XBP1
Ann-Hwee Lee et al.
SCIENCE (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
The endoplasmic reticulum stress response in immunity and autoimmunity
Derrick J. Todd et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The transcription factor XBP-1 is essential for the development and survival of dendritic cells
Neal N. Iwakoshi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells
Emma L. Davenport et al.
BLOOD (2007)
Donor CD4(+) T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease
Patricia Ewing et al.
EXPERIMENTAL HEMATOLOGY (2007)
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis
Daniel R. Carrasco et al.
CANCER CELL (2007)
MLN120B, a novel IκB kinase β inhibitor, blocks multiple myeloma cell growth in vitro and in vivo
Teru Hideshima et al.
CLINICAL CANCER RESEARCH (2006)
Targeting XBP-1 as a novel anti-cancer strategy
Albert C. Koong et al.
CANCER BIOLOGY & THERAPY (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
Teru Hideshima et al.
BLOOD (2006)
Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells
M Nakamura et al.
LEUKEMIA & LYMPHOMA (2006)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification of genes modulated in multiple myeloma using genetically identical twin samples
NC Munshi et al.
BLOOD (2004)
XBP1 is essential for survival under hypoxic conditions and is required for tumor growth
L Romero-Ramirez et al.
CANCER RESEARCH (2004)
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
AH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response
NN Iwakoshi et al.
IMMUNOLOGICAL REVIEWS (2003)
P58IPK, a novel endoplasmic reticulum stress-inducible protein and potential negative regulator of eIF2α signaling
R van Huizen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
T Hideshima et al.
BLOOD (2003)
XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response
AH Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1α
MG Marcu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Identification and characterization of a novel endoplasmic reticulum (ER) DnaJ homologue, which stimulates ATPase activity of BiP in vitro and is induced by ER stress
Y Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor
H Yoshida et al.
CELL (2001)
Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc12 and perturbing the cellular redox state
KD McCullough et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1
F Urano et al.
SCIENCE (2000)
Share Paper
